Home » About » Dr. Cristin Slater

Cristin C. Slater, M.D.

cristin_slater

Dr. Cristin C. Slater is a board certified reproductive endocrinologist and infertility specialist. She received her bachelor’s degree in 3 years from the University of Utah, majoring in health sciences while minoring in both chemistry and philosophy. She received her medical degree from the University of Utah in 1993. She completed her specialty training in obstetrics and gynecology at Harbor-UCLA Medical Center. Subsequently, she completed her sub-specialty fellowship training in Reproductive Endocrinology and Infertility at the University of Southern California. Prior to joining the Idaho Center for Reproductive Medicine, Dr. Slater practiced as an assistant professor in the division of Reproductive Endocrinology and Infertility for 3 years at the University of Southern California, where she taught medical students and reproductive endocrinology fellows.

Dr. Slater is well trained in laparoscopic, hysteroscopic, and microscopic surgery as well as with advanced reproductive technologies and hormone management. She has written 3 chapters in medical text books and published many articles in prestigious medical journals. She is active in various regional and national medical societies where she has presented her research. Locally, Dr. Slater continues to teach medical students and residents, as well as continuing to lecture for local physicians on topics in the field of reproductive endocrinology and infertility.

Personally, Dr. Slater is married and is the mother of twin boys. She enjoys the many various outdoor recreational activities that Boise has to offer.

Curriculum Vitae

EDUCATION

  • College
    University of Utah, Salt Lake City, Utah
    B.S., Health Sciences/Chemistry
    1986-1989
  • Medical School
    University of Utah, Salt Lake City, Utah
    M.D.
    1989-1993
  • Internship
    Department of Obstetrics and Gynecology
    Northwest Texas Hospital
    Texas Tech University
    1993-1994
  • Residency
    Department of Obstetrics and Gynecology
    Northwest Texas Hospital
    Texas Tech University
    Amarillo, Texas
    1994-1995
  • Residency
    Department of Obstetrics and Gynecology
    Harbor-UCLA Medical Center
    Torrance, California
    1995-1997
  • Fellowship
    Division of Reproductive Endocrinology and
    Infertility
    Department of Obstetrics and Gynecology
    Women’s and Children’s Hospital
    LAC+USC Medical Center
    Los Angeles, California
    1997-1999

LICENSURE

  • California Medical License
  • Idaho Medical License
  • Idaho Pharmacy License
  • Utah Medical License
  • Utah Controlled Substance License
  • DEA License

BOARD CERTIFICATIONS

  • The American Board of Obstetrics and Gynecology, Inc., Board Certified #971040
  • The American Board of Obstetrics and Gynecology, Inc., Division of Reproductive Endocrinology and Infertility, Board Certified

PROFESSIONAL BACKGROUND

  • 08/05/02 – current Reproductive Endocrinologist Idaho Center for Reproductive Medicine 111 Main Street, Suite #100 Boise, Idaho 83712
  • 07/01/99 – 07/26/02 Assistant Professor of Clinical Obstetrics and Gynecology Keck School of Medicine of the University of Southern California Los Angeles, California

TEACHING RESPONSIBILITIES

  • Teacher: University of Washington medical students, 2002-current
  • Lecturer: Physician Assistant Program, University of Southern California School of Medicine, Los Angeles, California, 1998 – 2002
  • Lecturer: Year 3 medical student clinical clerkship lectures, Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California, 1999 – 2002
  • Lecturer: Various topics in reproductive endocrinology and infertility for residents, University of Southern California Keck School of Medicine, Los Angeles, California, 1999 – 2002

ADMINISTRATIVE RESPONSIBILITIES

  • Interview and rank applicants for residency in the Department of Obstetrics and Gynecology, University of Southern California/Keck School of Medicine, 1998-2002
  • Interview and rank applicants for fellowship in reproductive endocrinology and Infertility, University of Southern California/Keck School of Medicine, 1998-2002
  • Interview medical school applicants for the University of Southern California Keck School of Medicine, 1999-2002
  • Member, Quality Assurance Committee, Women’s and Children’s Hospital, LAC+USC Medical Center, 1999-2002
  • Representative for Department of Obstetrics and Gynecology, Medical Faculty Assembly, Keck School of Medicine of the University of Southern California, 2000-2002

HOSPITAL AFFILIATIONS

  • Saint Luke’s Hospital
  • Saint Alphonsus Hospital

AD HOC EDITORIAL BOARD

  • Fertility and Sterility
  • Obstetrics and Gynecology

SOCIETY MEMBERSHIPS

  • The American Society for Reproductive Medicine
  • The North American Menopause Society
  • The Pacific Coast Reproductive Society
  • The Ada County Medical Society

AWARDS

  • Serono In-Training Award (first prize) for abstract entitled: “Altered balance between the 5a-reductase and aromatase pathways during ovarian stimulation with HMG.” Presented at the 46th Annual Meeting of the Pacific Coast Fertility Society, April 22-26, 1998, Indian Wells, California.
  • Wyeth-Ayerst Menopausal Award, co-author for abstract entitled: “Effects of oral and transdermal estradiol on the growth hormone/IGF-1 axis in relation to the immune system.” Presented at the 46th Annual Meeting of the Pacific Coast Fertility, April 22-26, 1998, Indian Wells, California.
  • Serono In-Training Award (second prize) for abstract entitled: “Estrone sulfate as a predictor of gonadotropin response during controlled ovarian hyperstimulation (COH).” Presented at the 47th Annual Meeting of the Pacific Coast Reproductive Society, April 14-18, 1999, Carlsbad, California.
  • Wyeth-Ayerst Award (most outstanding paper of the meeting), co-author for abstract entitled: “Vaginal administration of estradiol in preparation for oocyte donation.” Presented at the 47th Annual Meeting of the Pacific Coast Reproductive Society, April 14-18, 1999, Carlsbad, California.
  • Outstanding Teaching Award. Presented to a fellow each year by the graduating residents in Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, California, June 4, 1999.
  • Wyeth-Ayerst Menopausal Award for abstract entitled: “Dihydrotestosterone (DHT) accumulation as a consequence of long-term DHEA supplementation in postmenopausal women.” Presented at the 48th Annual Meeting of the Pacific Coast Reproductive Society, April 26-30, 2000, Rancho Mirage, California.
  • Wyeth-Ayerst Menopausal Award for abstract entitled: “Excessive serum testosterone levels are found during testosterone replacement therapy in postmenopausal women.” Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.
  • Fellow/Resident Award, co-author for abstract entitled: “Very high FSH levels do not result in additional follicular development in poor responders to ovarian stimulation.” Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.
  • Val Davajan Memorial Award, co-author for abstract entitled: “Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: Impact of GnRH Agonist vs. Antagonist.” Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.

GRANTS

  1. Title: “A multicenter, randomized, open-label, parallel group study to evaluate the endometrial safety following treatment with ORTHO-PREFESTâ compared to PREMPROä in overweight menopausal women.”
    Sponsor: Ortho-McNeil Pharmaceuticals, Inc.
    Period: June, 2001 – August, 2002
  2. Title: “A multicenter, double-blind, randomized, placebo-controlled study to evaluate the effect of a continuous-combined HRT preparation containing 1 mg estradiol and 3 mg drospirenone on blood pressure in mildly hypertensive postmenopausal women.”
    Sponsor: Berlex Laboratories, Inc.
    Grant period: 2001
    LIST OF PUBLICATIONS

    Peer Review Journals:
  • Tourgeman DE, Slater CC, Stanczyk FZ, Paulson RJ: “Endocrine and clinical effects of micronized estradiol administered vaginally or orally.” Fertil Steril 2001;75:200-2.
  • Slater CC, Hodis HN, Mack WJ, Shoupe D, Paulson RJ, Stanczyk FZ: “Markedly elevated levels of estrone sulfate following long-term oral, but not transdermal, administration of estradiol in postmenopausal women.” Menopause 2001;8:200-3.
  • Slater CC, Souter I, Zhang C, Guan C, Stanczyk FZ, Mishell DR Jr: “Pharmacokinetics of testosterone after percutaneous gel or buccal administration.” Fertil Steril 2001;76:32-7.
  • Slater CC, Chang L, Stanczyk FZ, Paulson RJ: “Altered balance between the 5a-reductase and aromatase pathways of androgen metabolism during controlled ovarian hyperstimulation with human menopausal gonadotropins.” J Assist Reprod Genet 2001;18:527-33.
  • Boostanfar R, Jain JK, Slater CC, Tourgeman DE, Francis MM, Paulson RJ: “The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system.” J Assist Reprod Genet 2001;18:548-50.
  • Slater CC, Zhang C, Hodis HN, Mack WJ, Boostanfar R, Shoupe D, Paulson RJ, Stanczyk FZ: “Comparison of estrogen and androgen levels after oral estrogen replacement therapy.” J Reprod Med 2001; 46:1052-6.
  • Paulson RJ, Boostanfar R, Saadat R, Mor E, Tourgeman DE, Slater CC, Francis MM, Jain JK: “Pregnancy in the Sixth Decade of Life: Obstetric Outcomes in Women of Advanced Reproductive Age.” JAMA 2002;288:2320-3.
  • Slater CC, Mack WJ, Xiang M, Shoupe D, Paulson RJ, Stanczyk FZ, Liu C-R, Liu C-H, Hodis HN: “ Subclinical atherosclerosis in healthy oophorectomized women.” Submitted to Fertil Steril.
  • Slater CC, Parks KS, Beatty H, Zhang C, Paulson RJ, Stanczyk FZ, Mishell DR Jr: “Androgen levels before and after oophorectomy.” In preparation.
  • Jain JK, Boostanfar R, Slater CC, Francis MM, Paulson RJ: “Blastocyst transfer is associated with an increased rate of monozygotic twins.” In preparation.
  • Hameed AB, Hodis HN, Xiang M, Roy S, Slater CC, Stanczyk FZ, Lobo RA, Liu C-R, Liu C-H, Mack WJ: “Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: Results from the estrogen in the prevention of atherosclerosis trial (EPAT).” In preparation.

CHAPTERS

  1. Slater CC, Shoupe D: “Polycystic ovarian syndrome.” Mishell DR Jr, Goodwin TM, Brenner PF, editors, Management of Common Problems in Obstetrics and Gynecology, Fourth Edition, pp. 364-7, 2002. Blackwell Science, Inc., Malden, Massachusetts.
  2. Slater CC: “Tubal factor infertility.” Mishell DR Jr, Goodwin TM, Brenner PF, editors, Management of Common Problems in Obstetrics and Gynecology, Fourth Edition, pp. 406-8, 2002. Blackwell Science, Inc., Malden, Massachusetts.
  3. Slater CC: “Tubal factor infertility: Treatment.” Mishell DR Jr, Goodwin TM, Brenner PF, editors, Management of Common Problems in Obstetrics and Gynecology, Fourth Edition, pp. 409-10, 2002. Blackwell Science, Inc., Malden, Massachusetts.

ABSTRACTS

  1. Coulam C, Acacio BD, Patel SK, Mack WJ, Hodis HN, Mistry JS, Ranadive GN, Savjani G, Shoupe D, Paulson RJ, Stanczyk FZ: “Accumulation of estrone sulfate following long-term oral and transdermal administration of estradiol in postmenopausal women.” Presented at the 45th Annual Meeting of the Society For Gynecologic Investigation, March 11-14, 1998, Atlanta, Georgia.
  2. Coulam C, Gray JD, Gentzschein E, Paulson RJ, Stanczyk FZ: “Effects of oral estrogen replacement on cytokine production in post-menopausal women.” Presented at the 45th Annual Meeting of the Society For Gynecologic Investigation, March 11-14, 1998, Atlanta, Georgia.
  3. Coulam C, Chang L, Zhang C, Jacob CO, Stanczyk FZ: “Is 17-hydroxylase/C17,20-lase activity impaired in patients with systemic lupus erythematous? “ Presented at the 45th Annual Meeting of the Society For Gynecologic Investigation, March 11-14, 1998, Atlanta, Georgia.
  4. Coulam C, Chang L, Paulson RJ, Stanczyk FZ: “Altered balance between the 5a-reductase and aromatase pathways during ovarian stimulation with HMG.” Presented at the 46th Annual Meeting of the Pacific Coast Fertility Society, April 22-26, 1998, Indian Wells, California.
  5. Cho MM, Coulam C, Stanczyk FZ, Paulson RJ: “The ovarian contribution to serum levels of vascular endothelial growth factor during stimulated cycles.” Presented at the 46th Annual Meeting of the Pacific Coast Fertility Society, April 22-26, 1998, Indian Wells, California.
  6. Bello SM, Gray JD, Navidazeh N, Gentzschein E, Coulam C, Shoupe D, Stanczyk FZ: “Effects of oral and transdermal estradiol on the growth hormone/IGF-1 axis in relation to the immune system.” Presented at the 46th Annual Meeting of the Pacific Coast Fertility Society, April 22-26, 1998, Indian Wells, California.
  7. Coulam C, Chang L, Stanczyk FZ, Paulson RJ: “Comparison of 5a-reductase and aromatase pathways during ovarian stimulation with different gonadotropic formulations.” Presented at the joint meeting of the 16th World Congress on Fertility and Sterility and the 54th Annual Meeting of The American Society for Reproductive Medicine, IFFS’98, October 4-9, 1998, San Francisco, California.
  8. Coulam C, Stanczyk FZ, Gray JD, Ramos DE, Paulson RJ, Roy S: “DHEA modulates cytokine production in post-menopausal women.” Presented at the 46th Annual Meeting of the Society for Gynecologic Investigation, March 10-13, 1999, Atlanta, Georgia.
  9. Coulam C, Stanczyk FZ, Paulson RJ: “Estrone sulfate as a predictor of gonadotropin response during controlled ovarian hyperstimulation (COH).” Presented at the 47th Annual Meeting of the Pacific Coast Reproductive Society, April 14-18, 1999, Carlsbad, California.
  10. Tourgeman DE, Coulam C, Stanczyk FZ, Paulson RJ: “Vaginal administration of estradiol in preparation for oocyte donation.” Presented at the 47th Annual Meeting of the Pacific Coast Reproductive Society, April 14-18, 1999, Carlsbad, California.
  11. Tourgeman DE, Coulam C, Stanczyk FZ, Paulson RJ: “Vaginal administration of oestradiol in preparation for oocyte donation.” Presented at the 15th Annual Meeting of the European Society of Human Reproduction and Embryology, June 26-30, 1999, Tours, France.
  12. Coulam C, Acacio BD, Hodis HN, Paulson RJ, Stanczyk FZ: “Correlation between plasma estradiol (E2) and estrone sulfate (E1-S) levels following long-term oral and transdermal administration of estradiol in healthy postmenopausal women (PMW).” Presented at the Conjoint Annual Meeting of the American Society for Reproductive Medicine (55th) and the Canadian Fertility and Andrology Society, September 25-30, 1999, Toronto, Ontario, Canada.
  13. Slater CC, Zhang C, Shoupe D, Paulson RJ, Xiang M, Mack W, Hodis H, Stanczyk FZ: “Low free testosterone and excessive estrogen levels in serum during 3 years of treatment with oral estradiol in postmenopausal women.” Presented at the 47th Annual Meeting of the Society for Gynecologic Investigation, March 22-25, 2000, Chicago, Illinois.
  14. Slater CC, Zhang C, Guan C, Huang R, Paulson RJ, Roy S, Stanczyk FZ: “Dihydrotestosterone (DHT) accumulation as a consequence of long-term DHEA supplementation in postmenopausal women.” Presented at the 48th Annual Meeting of the Pacific Coast Reproductive Society, April 26-30, 2000, Rancho Mirage, California.
  15. Boostanfar R, Jain JK, Tourgeman DE, Slater CC, Francis MM, Paulson RJ: “Blastocyst transfer is associated with an increased rate of monozygotic twins.” Presented at the 48th Annual Meeting of the Pacific Coast Reproductive Society, April 26-30, 2000, Rancho Mirage, California.
  16. Slater C, Souter I, Stanczyk F, Mishell DR Jr.: “Postmenopausal testosterone replacement via gel and lozenge form.” Presented at the annual meeting of the American College of Obstetricians and Gynecologists, Districts VIII and IX, August 4-6, 2000, Anchorage, Alaska.
  17. Parks KS, Stanczyk FZ, Slater CC, Zhang C, Guan C, Mishell DR Jr.: “Androgen levels before and after prophylactic oophorectomy.” Presented at the annual meeting of The American College of Obstetricians and Gynecologists, Districts VIII and IX, August 4-6, 2000, Anchorage, Alaska.
  18. Slater C, Shoupe D, Mack WJ, Lobo RA, Hodis HN: “Subclinical atherosclerosis is elevated in oophorectomized healthy postmenopausal women (PMW).” Presented at the 56th Annual Meeting of The American Society for Reproductive Medicine, October 21-26, 2000, San Diego, California.
  19. Parks KS, Stanczyk FZ, Slater CC, Zhang C, Guan C, Mishell DR Jr.: “Androgen levels before and after prophylactic oophorectomy.” Presented at the 67th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, November 14-19, 2000, Kamuela, Hawaii.
  20. Jain JK, Slater CC, Francis MM, Paulson RJ: “Monozygotic triplets following blastocyst transfer.” Presented at the 8th World Congress of Gynecological Endocrinology, December 6-9, 2000, Florence, Italy.
  21. Slater C, Zhang C, Guan C, Paulson RJ, Roy S, Stanczyk FZ: “Potential use of DHEA supplementation for estrogen and androgen replacement in postmenopausal women.” Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, March 14-17, 2001, Toronto, Ontario, Canada.
  22. Slater CC, Souter I, Stanczyk FZ, Zhang C, Paulson RJ, Mishell DR Jr.: “Pharmacokinetics of postmenopausal testosterone replacement following percutaneous gel or buccal administration.” Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, March 14-17, 2001, Toronto, Ontario, Canada.
  23. Slater CC, Stanczyk FZ, Zhang C, Paulson RJ, Mishell DR Jr.: “Excessive serum testosterone levels are found during testosterone replacement therapy in postmenopausal women.” Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.
  24. Slater CC, Shoupe D, Mack WJ, Stanczyk FZ, Hodis HN: “Evaluation of baseline carotid artery intima-media thickness and its progression over two years in postmenopausal women with and without intact ovaries.” Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.
  25. Slater CC, Parks KS, Stanczyk FZ, Zhang C, Paulson RJ, Mishell DR Jr.: “Androgen levels prior to, and following prophylactic oophorectomy.” Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.
  26. Saadat P, Slater CC, Patel S, Jain JK, Stanczyk FZ, Paulson RJ: “Very high FSH levels do not result in additional follicular development in poor responders to ovarian stimulation.” Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.
  27. Boostanfar R, Sorensen L, Ambroggio J, Jain JK, Slater CC, Francis MM, Paulson RJ: “Pregnancy outcome in women 50 or more years of age: A decade of experience.” Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25-29, 2001, Rancho Mirage, California.
  28. Boostanfar R, Jain JK, Slater CC, Tourgeman DE, Francis M, Paulson RJ: “The prognostic significance of day 3 embryo cleavage stage on subsequent blastocyst development in a sequential culture system.” Presented at the 17th Annual Meeting of the European Society of Human Reproduction and Embryology, July 1-4, 2001, Lausanne, Switzerland.
  29. Boostanfar R, Campeau JD, Saadat P, Tourgeman DE, Slater CC, Jain JK, diZerega GS, Kobak WH: “Use of the Harmonic Scapelâ as a novel technique for distal neosalpingostomy.” Presented at the 30th Annual Meeting of the American Association of Gynecologic Laparoscopists, November 16-19, 2001, San Francisco, California.
  30. Slater CC, Parks KS, Paulson RJ, Stanczyk FZ, Mishell DR Jr.: “Androgen levels before and after bilateral oophorectomy.” Presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, March 20-23, 2002, Los Angeles, California.
  31. Saadat P, Mor E, Slater CC, Stanczyk FZ, Paulson RJ, Shoupe D, Hodis HN, Mack WJ: “Postmenopausal oral estrogen replacement therapy and changes in blood pressure: A randomized placebo-controlled trial.” Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.
  32. Boostanfar R, Slater C, Klumph S, Saadat P, Tourgeman D, Paulson RJ: “Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: Impact of GnRH agonist vs. antagonist.” Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.
  33. Mor E, Saadat P, Zhang C, Stanczyk FZ, Slater CC, Jain J, Tourgeman D, Paulson RJ: “Ovarian and adrenal androgen profiles in cycles of controlled ovarian hyperstimulation utilizing GnRH antagonists or agonists.” Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.